Comments on:

Amgen buying deCODE Genetics for $415 million

Back to the article » |
TRENTON, N.J. (AP) — Biotech pioneer Amgen Inc., in a bid for a big edge in using people's genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million. Amgen, the world's largest biotech company by revenue, and deCODE, based in Reykjavik, Iceland, announced the all-cash deal Monday. DeCODE, founded in...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.